Sancilio & Company Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Sancilio & Company Inc (SCI), a subsidiary of Sancilio Pharmaceuticals Company Inc is a drug development company that develops, manufactures and markets over the counter and generic prescription products. The company provides products such as omega-3, ludent sodium fluoride chewable tablets and multivitamin chewable tablets with fluoride and sodium fluoride drops. It offers services such as formulation development, analytical chemistry and packaging. SCI provides medicines that prevent common health problems and eliminate deficiencies. It develops Advanced Lipid Technologies using lipophilic compounds such as fatty acids, hormones, several vitamins, and many active pharmaceutical ingredients. SCI is headquartered in Riviera Beach, Florida, the US.

Sancilio & Company Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Sancilio & Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sancilio & Company Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sancilio & Company Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sancilio & Company Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sancilio & Company Inc, Medical Devices Deals, 2012 to YTD 2018 9
Sancilio & Company Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sancilio & Company Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Sancilio Pharma Raises USD5 Million in Venture Financing 11
Sancilio & Company Raises USD20 Million in Venture Financing 12
Sancilio & Company Raises US$2 Million In Venture Financing 13
Equity Offering 14
Sancilio Pharma Withdraws IPO 14
Sancilio Pharma Raises USD20 Million in Private Placement of Series C Preferred Stock 15
Sancilio & Company Inc - Key Competitors 16
Sancilio & Company Inc - Key Employees 17
Sancilio & Company Inc - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product Approvals 19
Sep 19, 2017: Sancilio Pharmaceuticals Company, Receives Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for Altemia a Treatment of Sickle Cell Disease (SCD) in Children 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Sancilio & Company Inc, Pharmaceuticals & Healthcare, Key Facts 2
Sancilio & Company Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sancilio & Company Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sancilio & Company Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sancilio & Company Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Sancilio & Company Inc, Medical Devices Deals, 2012 to YTD 2018 9
Sancilio & Company Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sancilio Pharma Raises USD5 Million in Venture Financing 11
Sancilio & Company Raises USD20 Million in Venture Financing 12
Sancilio & Company Raises US$2 Million In Venture Financing 13
Sancilio Pharma Withdraws IPO 14
Sancilio Pharma Raises USD20 Million in Private Placement of Series C Preferred Stock 15
Sancilio & Company Inc, Key Competitors 16
Sancilio & Company Inc, Key Employees 17

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Sancilio and Company Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sancilio & Company Inc (SCI), a subsidiary of Sancilio Pharmaceuticals Company Inc is a drug development company that develops, manufactures and markets over the counter and generic prescription products. The

USD 250 View Report

Sancilio & Company Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sancilio & Company Inc (SCI), a subsidiary of Sancilio Pharmaceuticals Company Inc is a drug development company that develops, manufactures and markets over the counter and generic prescription products. The

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available